Patent · US Active

Components and methods for producing toxic RNAs in eukaryotic cells

US11312958B2 · kind B2 · utility

0Cited by
2References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 19, 2020
Grant dateApr 26, 2022
Priority date
Expiry dateMar 19, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2740/16043
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Disclosed are components and methods for producing toxic RNAs and/or extracellular vesicles comprising the toxic RNAs in cells that are resistant to the toxic RNAs, which toxic RNAs may include toxic shRNA/siRNA and/or toxic pre-miRNA/miRNA. The disclosed components may include engineered cells that can be utilized to express the toxic RNAs, in which the engineered cells do not express one or more genes that are required for processing the toxic RNAs for RNA interference (RNAi) and/or one or more genes that are required for executing RNAi. The toxic RNAs and/or extracellular vesicles comprising the toxic RNAs may be utilized in methods for treating diseases and disorders through RNAi.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.